Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Fentonium bromide [INN]
RN: 5868-06-4
UNII: XS152O7VCZ
InChIKey: MPLNGQBULSHWQW-QRAMOEPWSA-M

Note

  • Less effect on eye, heart & gland functions than atropine; proposed for therapy of gastrointestinal ulcers.

Molecular Formula

  • C31-H34-N-O4.Br

Molecular Weight

  • 564.5166
 

Classification Code

  • Drug / Therapeutic Agent
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Fentonium
  • Fentonium bromide
  • Fentonium bromide [INN]

Synonyms

  • 3-alpha-Hydroxy-8-(p-phenylphenacyl)-1-alpha-H,5-alpha-H-tropanium bromide (-)-tropate
  • Bromure de fentonium
  • Bromure de fentonium [INN-French]
  • Bromuro de fentonio
  • Bromuro de fentonio [INN-Spanish]
  • EINECS 227-520-2
  • FA 402
  • Fentonii bromidum
  • Fentonii bromidum [INN-Latin]
  • Fentonio bromuro
  • Fentonio bromuro [DCIT]
  • Fentonium bromide
  • Ketoscilium
  • N-(4-Phenylphenacyl)-1-hyoscyaminium bromide
  • Phentonium bromide
  • Ulcesium
  • UNII-XS152O7VCZ
  • Z 326

Systematic Names

  • 1-alpha-4,5-alpha-H-Tropanium, 3-alpha-hydroxy-8-(p-phenylphenacyl)-, bromide, (-)-tropate
  • 3alpha-Hydroxy-8-(p-phenylphenacyl)-1alphaH,5alphaH-tropanium bromide (-)-tropate
  • Fentonium bromide

Registry Numbers

CAS Registry Number

  • 5868-06-4

FDA UNII

  • XS152O7VCZ

System Generated Number

  • 0005868064

Molecular Formulas

Molecular Formula

  • C31-H34-N-O4.Br

Molecular Formula Fragments

  • Br
  • C31-H34-N-O4
  • COMPONENT

Structure Descriptors

InChI

1S/C31H34NO4.BrH/c1-32(20-30(34)25-14-12-23(13-15-25)22-8-4-2-5-9-22)26-16-17-27(32)19-28(18-26)36-31(35)29(21-33)24-10-6-3-7-11-24;/h2-15,26-29,33H,16-21H2,1H3;1H/q+1;/p-1/t26-,27+,28+,29-,32-;/m1./s1

InChIKey

MPLNGQBULSHWQW-QRAMOEPWSA-M

Smiles

[Br-].C[N@+]1(CC(=O)c2ccc(cc2)c3ccccc3)[C@H]4CC[C@@H]1C[C@@H](C4)OC(=O)[C@H](CO)c5ccccc5

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intravenous 10mg/kg (10mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
United States Patent Document. Vol. #3356682,
mouse LD50 intravenous 12100ug/kg (12.1mg/kg)   United States Patent Document. Vol. #3356682,
mouse LD50 oral > 400mg/kg (400mg/kg)   United States Patent Document. Vol. #3356682,
mouse LD50 subcutaneous > 400mg/kg (400mg/kg)   United States Patent Document. Vol. #3356682,
rat LD50 intravenous 11600ug/kg (11.6mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
United States Patent Document. Vol. #3356682,